Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy.
about
A systematic review of validated methods for identifying lymphoma using administrative data.Outpatient treatment costs and their potential impact on cancer care.Conducting high-value secondary dataset analysis: an introductory guide and resources.Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough?Impact of payment reform on chemotherapy at the end of life.Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational studyChanges in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007Market Size and Innovation: Effects of Medicare Part D on Pharmaceutical Research and Development.Hospital characteristics associated with timeliness of care in veterans with lung cancer.The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United StatesPrivate Practice Administrative Costs Influenced by Insurance Payer Mix.Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer.Medicare reimbursement and the use of biologic agents: incentives, access, the public good, and optimal care.Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients.Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer.
P2860
Q34133911-059B1239-66E5-401B-9662-4D8DF4E75719Q34982568-620DDAA2-6AB1-445E-9C8F-B3385286CCF3Q35113156-AFD9D697-A7EB-4E9E-95A9-A800E8A2D40AQ35133471-3A27992C-7456-4C37-B768-0DBC34FDA654Q35947730-8A04E791-16EC-439E-8242-C091F4A3FF45Q36080801-1639B569-2DB1-4742-B074-3ABDF60ACA29Q36163573-F8BFA7B2-8B05-43C8-B552-E92DCC00CA6CQ37014496-B02D463A-A255-43A1-9A24-47B526ED98D6Q37307289-270CB10D-FF94-4A6F-B34F-827B68380CBFQ37310102-38FDEAEE-9CCA-40B4-88FE-FB10880D7522Q37416800-A1D3C838-FD2D-4838-B71D-06B248EA812EQ39717577-950C4E65-DFDD-407B-8297-72D78AF87099Q42565805-F744069A-19DD-485C-B6D3-EB2AD0E72EC1Q50146461-42D40C51-D9BF-4AB8-906A-28947E5838BFQ53709840-B3567F1C-D2C2-4DDF-A532-71D87E2C6CC5
P2860
Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Association between the Medica ...... vel distance for chemotherapy.
@en
Association between the Medica ...... vel distance for chemotherapy.
@nl
type
label
Association between the Medica ...... vel distance for chemotherapy.
@en
Association between the Medica ...... vel distance for chemotherapy.
@nl
prefLabel
Association between the Medica ...... vel distance for chemotherapy.
@en
Association between the Medica ...... vel distance for chemotherapy.
@nl
P2093
P356
P1476
Association between the Medica ...... vel distance for chemotherapy.
@en
P2093
Alisa M Shea
Bradley G Hammill
Kevin A Schulman
Lesley H Curtis
Lisa D DiMartino
P304
P356
10.1001/JAMA.300.2.189
P407
P577
2008-07-01T00:00:00Z